Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

“RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD”. P. CALVERLEY, R. PAUWELS, C-G. LÖFDAHL, K. SVENSSON, T. HIGENBOTTAM, L-G. CARLSSON AND E. STÅHL. EUR RESPIR J 2005; 26: 406–413.

European Respiratory Journal 2006 27: 440; DOI: 10.1183/09031936.06.50143404
  • Article
  • Info & Metrics
  • PDF
Loading

Unfortunately, a small section of text in the above paper (in the Results, Individual changes: combined symptom scores, Symptom mean exceeding a set value) was reported incorrectly. It should have appeared as follows. “Symptom-based events, defined as a mean symptom value exceeding a level of 1.5, 2.0 or 2.5 for 3 consecutive days, showed a relatively high degree of concurrence at the lower levels (table 4). A symptom-based exacerbation, defined as a level of 1.5 for 3 days, was seen in almost all patients at some point, 63.3% correlating with an event-based exacerbation.” The authors apologise for this error.

    • © ERS Journals Ltd
    PreviousNext
    Back to top
    View this article with LENS
    Vol 27 Issue 2 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    “RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD”. P. CALVERLEY, R. PAUWELS, C-G. LÖFDAHL, K. SVENSSON, T. HIGENBOTTAM, L-G. CARLSSON AND E. STÅHL. EUR RESPIR J 2005; 26: 406–413.
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    “RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD”. P. CALVERLEY, R. PAUWELS, C-G. LÖFDAHL, K. SVENSSON, T. HIGENBOTTAM, L-G. CARLSSON AND E. STÅHL. EUR RESPIR J 2005; 26: 406–413.
    European Respiratory Journal Feb 2006, 27 (2) 440; DOI: 10.1183/09031936.06.50143404

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    “RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD”. P. CALVERLEY, R. PAUWELS, C-G. LÖFDAHL, K. SVENSSON, T. HIGENBOTTAM, L-G. CARLSSON AND E. STÅHL. EUR RESPIR J 2005; 26: 406–413.
    European Respiratory Journal Feb 2006, 27 (2) 440; DOI: 10.1183/09031936.06.50143404
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • “Interstitial lung abnormalities are associated with decreased mean telomere length.” R.K. Putman, G.T. Axelsson, S.Y. Ash, et al. Eur Respir J 2022; 60: 2101814
    • “Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis.” S.M. Kawut, M.J. Krowka, K.A. Forde, N. Al-Naamani, K.L. Krok, M. Patel, C.R. Bartoli, M. Doyle, J. Moutchia, G. Lin, J.K. Oh, C.D. Mottram, P.D. Scanlon and M.B. Fallon for the Pulmonary Vascular Complications of Liver Disease Study Group. Eur Respir J 2022; 60: 2102304.
    • “Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics.” M. Badran, A. Khalyfa, A.C. Ericsson, C. Puech, Z. McAdams, S.B. Bender and D. Gozal. Eur Respir J 2023; 61: 2200002.
    Show more Author Correction

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society